SHMT2 and pancreatic ductal adenocarcinoma: Immunohistochemical analyses of 103 pancreatic ductal adenocarcinoma samples revealed that high SHMT2 expression was significantly associated with poor OS but not with DFS (Noguchi et al., 2018).